Company Filing History:
Years Active: 1990-1998
Title: Eiko Ohtsuka: Innovator in Elastase Inhibition
Introduction: Eiko Ohtsuka is a prominent inventor based in Sapporo, Japan, known for her significant contributions to the field of biochemistry and her innovative approach to protein production. With a total of three patents to her name, Ohtsuka's work aims to enhance therapeutic options in medical science, particularly in relation to elastase inhibition.
Latest Patents: One of Eiko Ohtsuka's most notable patents is the elastase inhibitory polypeptide and process for production thereof. This invention presents a polypeptide that comprises a C-terminal half of a human secretory leukocyte protease inhibitor (SLPI), which exhibits elastase inhibitory activity. Importantly, the inhibitory activity towards a trypsin-like serine protease does not exceed one-tenth of the elastase inhibitory activity. The patent also details the possibility of modifying the polypeptide by adding, deleting, or replacing amino acids, thereby providing versatility in its application.
Career Highlights: Ohtsuka's professional journey includes significant roles at renowned companies such as Teijin Limited and Sankyo Company, Limited, where she made lasting impacts through her research and innovative projects. Her expertise in biochemistry and proteins has led to advancements that could play crucial roles in therapeutic developments.
Collaborations: Throughout her career, Eiko Ohtsuka has collaborated with notable colleagues such as Kenichi Masuda and Takashi Kamimura. These collaborations have not only enriched her work but have also facilitated the exchange of ideas and fostered innovation within her field.
Conclusion: Eiko Ohtsuka stands out as a distinguished inventor whose contributions to elastase inhibition and protein production are set to advance medical science. Her patents reflect a commitment to innovation and collaboration, positioning her as a key player in the biochemistry domain.